Medication info

Draminju

Prescription medicationInjections
Ingredient · strength
L-Isoleucine›0.65g / 100mLL-Leucine›0.818g / 100mLL-Lysine Acetate›0.606g / 100mLL-Methionine›0.04g / 100mLL-Phenylalanine›0.055g / 100mLL-Threonine›0.275g / 100mLL-Tryptophan›0.044g / 100mLL-Valine›0.63g / 100mLL-Alanine›0.29g / 100mLL-Arginine›0.67g / 100mLL-Histidine›0.175g / 100mLL-Proline›0.358g / 100mLGlycine›0.373g / 100mLL-Serine›0.14g / 100mLAcetylcysteine›0.07g / 100mL
Manufacturer / importer
JW Life Science Co., Ltd.
Appearance
A transparent solution that is colorless to pale yellow contained in a polypropylene aqueous injection container.
Packaging
100mL/bag, 200mL/bag, 250mL/bag
Approval status
Active

MFDS item code 200805596 · Notified 2008.05.19

Summary

Main use
Amino acid supplementation therapy for severe hepatic impairment and hepatic coma
Who uses it
Adults
Adult dosage
○ Adults: Administer by intravenous infusion up to a maximum daily dose of 1.5 g of total amino acids per kg of body weight (equivalent to 2100 mL per day for a body weight of 70 kg). ○ Infusion rate: 1.7~2.1 mL per kg of body weight over 60 minutes (40~50 drops per minute for a body weight of 70 kg).

Ingredients

Manufacturer
JW Life Science Co., Ltd.

Efficacy & effects

Amino acid supplementation therapy for severe hepatic impairment and hepatic coma

  • Brain function impairment
  • severe liver dysfunction
  • hepatic coma.
View approved original text

This medication is used for severe liver dysfunction with or without brain function impairment, particularly in patients with liver failure, and is also effective in treating hepatic coma. In such cases, amino acids are supplied parenterally to support the patient's liver function and relieve symptoms. It is suitable for patients with significantly impaired liver function and plays an important role in enhancing therapeutic effects. Therefore, this drug is used for severe liver dysfunction and hepatic coma treatment.

Dosage and Administration

Adult dosage

○ Adults: Administer by intravenous infusion up to a maximum daily dose of 1.5 g of total amino acids per kg of body weight (equivalent to 2100 mL per day for a body weight of 70 kg). ○ Infusion rate: 1.7~2.1 mL per kg of body weight over 60 minutes (40~50 drops per minute for a body weight of 70 kg).

Precautions

This medication should be used strictly according to the doctor's instructions and should not be taken or stopped arbitrarily. Patients with severe renal dysfunction or elevated blood nitrogen levels should not be administered this medication. It is also safe not to administer this drug to patients with metabolic disorders affecting nitrogen utilization, severe heart failure, or pulmonary edema. Patients with very low or no urine output, those with elevated sodium and chloride levels, or those with alkalotic blood should avoid this medication due to certain components. If magnesium ions are included, it should not be used in patients with issues in cardiac electrical signal transmission or severe myasthenia gravis. It should also be avoided in patients with excessive water supply in the body or those with a history of myocardial infarction. Caution is required for patients with severe acidosis, congestive heart failure, or heart failure, and careful administration is required for patients with abnormal sodium or potassium levels, as certain components may trigger allergic reactions or asthmatic attacks. Rarely, hypersensitivity reactions such as skin rashes may occur, and gastrointestinal symptoms such as nausea or vomiting may also be experienced. Cardiac-related symptoms include discomfort in the chest, palpitations, rapid heartbeat, and elevated blood pressure. Rapid administration of large volumes may lead to metabolic acidosis due to acidification of the body. Additionally, chills, fever, headache, difficulty breathing, shock, bronchospasms, and urinary spasms may occur. If magnesium ions are included, peripheral vessels may dilate, causing a drop in blood pressure. Various metabolic abnormalities can occur, such as metabolic acidosis, hypophosphatemia, alkalosis, blood sugar abnormalities, dehydration, hypoglycemia, increased liver enzymes, vitamin imbalances, and electrolyte imbalances. Patients with weak liver or kidney function may experience elevated blood urea nitrogen levels, and those with severely impaired liver function may develop serious metabolic abnormalities leading to coma. When administering large doses of this drug or using it with other electrolyte-containing drugs, careful monitoring of the electrolyte balance is necessary. Overdose may lead to metabolic alkalosis, especially when using preparations with acetate ions. Patients with kidney, lung, or heart diseases should be cautious to avoid excessive water supply in the body. Diabetic patients should frequently measure and manage blood sugar levels during treatment with this drug. Patients with hyponatremia or impaired liver or kidney function need to carefully manage dosage and their fluid and electrolyte status. Interactions with other medications should also be approached cautiously; for example, using this medication with tetracycline antibiotics may reduce protein-sparing effects. If magnesium ions are included, caution is needed as precipitates may occur when administered with calcium preparations. The safety for pregnant women has not been established, so it should only be used cautiously in cases where the therapeutic benefit outweighs the risks. Children are at risk for hyperammonemia due to immature hepatic function, so concentrations should be kept low, and blood ammonia levels should be monitored frequently. Older adults require caution as bodily functions may be impaired, necessitating slower administration rates and dosage adjustments. When administering, special attention must be paid to electrolyte balance based on whether it contains electrolytes, and rapid intravenous administration may lead to chills or vomiting, so it should be given slowly. This medication must always be stored at an appropriate temperature, with strict maintenance of aseptic conditions during preparation and administration, and discolored or turbid solutions should not be used. Additionally, the solution should be used promptly after mixing and must be used within 24 hours if refrigerated, and if crystallization occurs, it should be appropriately reheated to dissolve. This medication must not be used if the packaging or container is damaged or has deteriorated.

Side effects

  • Rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • tachycardia
  • increased blood pressure
  • acidosis
  • chills
  • fever
Show 27 more
  • headache
  • dyspnea
  • respiratory arrest
  • shock
  • bronchospasm
  • urinary spasm
  • peripheral vascular dilation
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonaemia
  • elevated BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • systemic nitrogenemia
  • hyperammonemia
  • sensory loss
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering, and the storage temperature should be maintained at room temperature between 1 to 30 degrees Celsius. This way, the effectiveness of the medication can be safely maintained.

Appearance and packaging

Appearance

A transparent solution that is colorless to pale yellow contained in a polypropylene aqueous injection container.

Package unit

100mL/bag, 200mL/bag, 250mL/bag

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.